BTAI BioXcel Therapeutics
- 2.550
- 0.0000.00%
- 2.580
- +0.030+1.18%
BioXcel Therapeutics News
BioXcel Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
BioXcel Therapeutics | 8-K: Current report
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer O'Neill Vincent
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mehta Vimal
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Steinhart Richard I
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wiley Matthew T.
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodriguez Javier
BioXcel Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yocca Frank
BioXcel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
BioXcel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
BioXcel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
BioXcel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
BioXcel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
BioXcel Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
BioXcel Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BioXcel Therapeutics | 8-K: Current report
BioXcel Therapeutics | 424B5: Prospectus
BioXcel Therapeutics | 10-K: Annual report
BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
BioXcel Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
